Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway

Biochemical and Biophysical Research Communications

Volumn 308, Issue 4, 2003, Pages 990-994

  Tramontano, Anthony F ^a,b   Muniyappa, Ranganath ^a,b   Black, Aislinn D ^a   Blendea, Mihaela C ^b   Cohen, Inna ^a   Deng, Lili ^a   Sowers, James R ^a,b   Cutaia, Michael V ^a,b   El Sherif, Nabil ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Erythropoietin; Hypoxia; Neonatal cardiomyocyte

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ERYTHROPOIETIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG ACTIVITY; DRUG INHIBITION; ENZYME ACTIVITY; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INTERMETHOD COMPARISON; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL;

EID: 0041659121     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01503-1     Document Type: Article

References (24)

1. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA. 95:1998;4635-4640.
2. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum R.S., Cerami A., Brines M., Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA. 99:2002;10659-10664.
3. Akimoto T., Kusano E., Inaba T., Iimura I., Takahashi H., Ikeda H., Ito C., Ando Y., Ozawa K., Asano Y. Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway. Kidney Int. 58:2000;269-282.
4. Chong Z.Z., Kang J.Q., Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation. 106:2002;2973-2979.
5. Calvillo L., Latini R., Kajstrura J., Leri A., Anversa P., Ghezzi P., Salio M., Cerami A., Brines M. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl. Acad. Sci. USA. 100:2003;4802-4806.
6. Cai Z., Manalo D., Wei G., Rodriguez E.R., Fox-Talbot K., Lu H., Zweier J.L., Semenza G.L. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against Ischemia-reperfusion injury. Circulation. 107:2003;r107-r1130.
7. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA. 97:2000;10526-10531.
8. Kajstura J., Cheng W., Reiss K., Clark W.A., Sonnenblick E.H., Krajewski S., Reed J.C., Olivetti G., Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74:1996;86-107.
9. Akli S., Zhan S., Abdellatif M., Schneider M.D. E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2. Circ. Res. 85:1999;319-328.
10. + antiport activity, isoform expression, and localization in endothelial cells. Am. J. Physiol. 275:1998;L442-451.
11. Qin D., Zang Z.H., Caref E.B., Boutjdir M., Jain P., El-Sherif N. Cellular an ionic basis of arrhythmias in post infarction remodeled ventricular myocardium. Circ. Res. 76:1996;461-473.
12. El-Adawi H., Deng L., Tramontano A., Smith S., Mascareno E., Ganguly K., Castillo R., El-Sherif N. The functional role of the JAK-STAT pathway in post-infarction remodeling. Cardiovasc. Res. 57:2003;129-138.
13. Communal C., Sigh K., Pimental D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of. B -adrenergic pathway Circulation. 98:1998;1329-1334.
14. Juul S.E., Yachnis A.T., Christensen R.D. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum. Develop. 52:1998;235-249.
15. Acs G., Zhang P.J., Rebbeck T.R., Acs P., Verma A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer. 95:2002;969-981.
16. Tilbrook P.A., Klinken S.P. The erythropoietin receptor. Int. J. Biochem. Cell Biol. 31:1999;1001-1005.
17. Brar B.K., Stephanou A., Knight R., Latchman D.S. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J. Mol. Cell. Cardiol. 34:2002;483-492.
18. Kubasiak L.A., Hernandez O.M., Bishopric N.H., Webster K.A. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. USA. 99:2002;12825-12830.
19. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M.L., Ghezzi P. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalitis. Brain Res. 952:2002;128-134.
20. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature. 412:2001;641-647.
21. Haunstetter A., Izumo S. Apoptosis; basic mechanisms and implications for cardiovascular disease. Circ. Res. 81:1998;1111-1129.
22. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature. 40:1999;86-90.
23. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin A.S. Jr., Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20:2000;1626-1638.
24. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.